Remove Diabetes Remove Hospital Remove Hypertension Remove Patients
article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Population Studied individuals with comorbidity of hypertension and type 2 diabetes. Setting or Dataset Five electronic systems of community clinic.

article thumbnail

“The physician–patient encounter is health care’s choke point” -NEJM

A Country Doctor Writes

Its basic argument was that it isn’t sustainable to only see patients one by one in traditional doctor visits. I thought of it the other day when I put together a presentation about Galileo’s way of interacting with patients. The physician–patient encounter is health care’s choke point.

Patients 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes [Diabetes and endocrine disease]

Annals of Family Medicine

Objectives To assess overall medication adherence as an indicator for emergency room (ER) visits, hospitalizations, and mortality among elderly patients. We retrieved information on all ER visits and hospitalizations in internal medicine and surgical wards from 2017 to 2019 and mortality in 2019. The mean age was 81.2

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. and worldwide,” Paul Whelton, M.D., All rights reserved.

article thumbnail

Maria Ansari, MD, FACC, named to Modern Healthcare’s list of 50 Most Influential Clinical Executives

Permanente Medicine

. “This recognition honors the dedication of our Permanente physicians, clinicians, nurses, and staff who bring Permanente Medicine to life every day — delivering care that is compassionate, patient-centered, and seamlessly coordinated,” said Dr. Ansari. Improving physician wellness. million Kaiser Permanente members.

Clinic 59
article thumbnail

Reasoning during the COVID-19 pandemic

The Clinical Problem Solvers

No prior history of atrial fibrillation – just hypertension and diabetes. Had the ED not ordered a chest CT, would I have tested this patient for COVID-19? The patient I saw with atrial fibrillation and RVR likely wouldn’t even have merited testing in early March, yet he clearly had the disease in mid April.

Illness 52
article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

Medical societies and hospitals are weighing in on periprocedural concerns in patients taking GLP-1s who need procedures or surgeries. That’s according to two internists who work closely with hospitalized patients who take GLP-1s.